{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T13:01:57Z","timestamp":1775998917329,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"FAPERJ","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biophysical Chemistry"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.bpc.2023.107041","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T06:51:08Z","timestamp":1684133468000},"page":"107041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Mutations in asparaginase II from E. coli and implications for inactivation and PEGylation"],"prefix":"10.1016","volume":"299","author":[{"given":"Mariana T.Q.","family":"de Magalh\u00e3es","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talita Stelling","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Marques","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Pe\u00f1a","family":"Icart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra M.N.","family":"Scapin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcius","family":"da Silva Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds Maur\u00edcio T.R.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpc.2023.107041_bb0005","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0003-9861(64)90032-3","article-title":"Tumor inhibitory effect of L-ASPARAGINASE from ESCHERICHIA COLI","volume":"105","author":"Mashburn","year":"1964","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.bpc.2023.107041_bb0010","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1021\/bi00855a011","article-title":"Two L-Asparaginases from Escherichia Coli B. Their separation, purification, and antitumor activity*","volume":"6","author":"Campbell","year":"1967","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.bpc.2023.107041_bb0015","first-page":"2619","article-title":"Inhibition of Leukemias in man by L-Asparaginase","volume":"27","author":"Oettgen","year":"1967","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bpc.2023.107041_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijo.2021.5191","article-title":"Human L-asparaginase: acquiring knowledge of its activation (review)","volume":"58","author":"De Morais","year":"2021","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.bpc.2023.107041_bb0025","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1128\/jb.96.6.2043-2048.1968","article-title":"Production of L-Asparaginase II by Escherichia Coli","volume":"96","author":"Cedar","year":"1968","journal-title":"J. Bacteriol."},{"issue":"5331","key":"10.1016\/j.bpc.2023.107041_bb0030","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1126\/science.277.5331.1453","article-title":"The complete genome sequence of Escherichia Coli K-12","volume":"277","author":"Blattner","year":"1997","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bpc.2023.107041_bb0035","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/oxfordjournals.jbchem.a130690","article-title":"Amino acid sequence of L-Asparaginase from Escherichia Coli","volume":"76","author":"Maita","year":"1974","journal-title":"J. Biochem."},{"issue":"2","key":"10.1016\/j.bpc.2023.107041_bb0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1385\/ABAB:95:2:093","article-title":"Cloning and expression of L-Asparaginase gene in Escherichia Coli","volume":"95","author":"Wang","year":"2001","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.bpc.2023.107041_bb0045","article-title":"Recombinant host for producing L-Asparaginase II","author":"Filpula","year":"2010","journal-title":"US7807436B2"},{"issue":"4","key":"10.1016\/j.bpc.2023.107041_bb0050","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1073\/pnas.90.4.1474","article-title":"Crystal structure of Escherichia Coli L-Asparaginase, an enzyme used in Cancer therapy","volume":"90","author":"Swain","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bpc.2023.107041_bb0055","first-page":"6","article-title":"Development of L-Asparaginase biobetters: current research status and review of the desirable quality profiles","author":"Brumano","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"13","key":"10.1016\/j.bpc.2023.107041_bb0060","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1182\/blood-2008-04-149443","article-title":"Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant Asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trial","volume":"112","author":"Pieters","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bpc.2023.107041_bb0065","first-page":"991","article-title":"FDA drug approval summary: Pegaspargase (Oncaspar\u00ae) for the first-line treatment of children with acute lymphoblastic leukemia (ALL)","volume":"12","author":"Dinndorf","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.bpc.2023.107041_bb0070","series-title":"Spectrila","author":"Anonymous","year":"2023"},{"key":"10.1016\/j.bpc.2023.107041_bb0075","author":"Registro ANVISA no 1562600310016 - Spectrila - V\u00c1LIDO"},{"issue":"6","key":"10.1016\/j.bpc.2023.107041_bb0080","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1128\/jb.95.6.2117-2123.1968","article-title":"New procedures for purification of L-Asparaginase with high yield from Escherichia Coli","volume":"95","author":"Roberts","year":"1968","journal-title":"J. Bacteriol."},{"issue":"4","key":"10.1016\/j.bpc.2023.107041_bb0085","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bjhh.2017.08.002","article-title":"Reactions related to Asparaginase infusion in a 10-year retrospective cohort","volume":"39","author":"Santos","year":"2017","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"10.1016\/j.bpc.2023.107041_bb0090","doi-asserted-by":"crossref","DOI":"10.1177\/10781552211007549","article-title":"Ammonia level as a proxy of Asparaginase inactivation in children: a strategy for classification of infusion reactions","author":"Santos","year":"2021","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"9","key":"10.1016\/j.bpc.2023.107041_bb0095","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(18)30584-9","article-title":"Monitoring Asparaginase activity in middle-income countries","volume":"19","author":"Cecconello","year":"2018","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.bpc.2023.107041_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(18)30656-9","article-title":"Monitoring Asparaginase activity","volume":"19","author":"Lima","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bpc.2023.107041_bb0105","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ebiom.2018.03.005","article-title":"Low bioavailability and high immunogenicity of a new brand of E. Coli l-Asparaginase with active host contaminating proteins","volume":"30","author":"Zenatti","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bpc.2023.107041_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2021.106554","article-title":"Biophysical characterization of two commercially available preparations of the drug containing Escherichia Coli L-Asparaginase 2","author":"de Ara\u00fajo","year":"2021","journal-title":"Biophys. Chem."},{"issue":"5","key":"10.1016\/j.bpc.2023.107041_bb0115","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.drudis.2020.02.002","article-title":"Impact of the protein data Bank on antineoplastic approvals","volume":"25","author":"Westbrook","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bpc.2023.107041_bb0120","article-title":"Staining of proteins in gels with Coomassie G-250 without organic solvent and acetic acid","volume":"No. 30","author":"Lawrence","year":"2009","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bpc.2023.107041_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/elps.200305844","article-title":"Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis","author":"Candiano","year":"2004","journal-title":"Electrophoresis"},{"issue":"7","key":"10.1016\/j.bpc.2023.107041_bb0130","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"5","key":"10.1016\/j.bpc.2023.107041_bb0135","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1107\/S0021889897001829","article-title":"The small-angle X-ray scattering beamline of the Brazilian synchrotron light laboratory","volume":"30","year":"1997","journal-title":"J. Appl. Crystallogr."},{"issue":"2","key":"10.1016\/j.bpc.2023.107041_bb0140","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1107\/S1600576716000455","article-title":"A multi-purpose data reduction, analysis and visualization program","volume":"49","year":"2016","journal-title":"J. Appl. Crystallogr."},{"issue":"4","key":"10.1016\/j.bpc.2023.107041_bb0145","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1107\/S1600576717007786","article-title":"ATSAS 2.8: a comprehensive data analysis suite for small-angle scattering from macromolecular solutions","volume":"50","year":"2017","journal-title":"J. Appl. Crystallogr."},{"issue":"3\u20134","key":"10.1016\/j.bpc.2023.107041_bb0150","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/elps.1150180314","article-title":"Detailed peptide characterization using PEPTIDEMASS\u2014a world-wide-web-accessible tool","volume":"18","author":"Wilkins","year":"1997","journal-title":"Electrophoresis"},{"issue":"Pt 4","key":"10.1016\/j.bpc.2023.107041_bb0155","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bpc.2023.107041_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2022.114594","article-title":"The reproducible normality of the crystallographic B-factor","author":"Ramos","year":"2022","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bpc.2023.107041_bb0165","first-page":"19","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","year":"2015","journal-title":"SoftwareX"},{"issue":"8","key":"10.1016\/j.bpc.2023.107041_bb0170","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/prot.22711","article-title":"Improved side-chain torsion potentials for the Amber Ff99SB protein force field","volume":"78","author":"Lindorff-Larsen","year":"2010","journal-title":"Proteins"},{"issue":"2","key":"10.1016\/j.bpc.2023.107041_bb0175","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"issue":"12","key":"10.1016\/j.bpc.2023.107041_bb0180","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u00b7log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"1","key":"10.1016\/j.bpc.2023.107041_bb0185","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"issue":"8","key":"10.1016\/j.bpc.2023.107041_bb0190","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external Bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bpc.2023.107041_bb0195","series-title":"Ggplot2; Use R!","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","author":"Wickham","year":"2016"},{"issue":"7","key":"10.1016\/j.bpc.2023.107041_bb0200","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"issue":"4","key":"10.1016\/j.bpc.2023.107041_bb0205","first-page":"4","article-title":"Pharmacopeia and ANVISA: a necessary Symbiosis","volume":"8","author":"Lima","year":"2017","journal-title":"RBFHSS"},{"issue":"6","key":"10.1016\/j.bpc.2023.107041_bb0210","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/bcp.14216","article-title":"A comparison of Asparaginase activity in generic formulations of E.Coli derived L- Asparaginase: in-vitro study and retrospective analysis of Asparaginase monitoring in pediatric patients with leukemia","volume":"86","author":"Sankaran","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bpc.2023.107041_bb0215","unstructured":"Colon, C. ABRALE apresentou questionamentos ao Minist\u00e9rio da Sa\u00fade quanto \u00e0 aquisi\u00e7\u00e3o de Asparaginase. Abrale https:\/\/www.abrale.org.br\/noticias\/abrale-apresentou-questionamentos-ao-ministerio-da-saude-quanto-a-aquisicao-de-asparaginase\/ (accessed 2022-11-21)."},{"issue":"11","key":"10.1016\/j.bpc.2023.107041_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29046","article-title":"Unsatisfactory quality of E. coli Asparaginase biogenerics in India: implications for clinical outcomes in acute lymphoblastic Leukaemia","volume":"68","author":"Sidhu","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bpc.2023.107041_bb0225","author":"ACP l-asparaginase \u2014 Procuradoria da Rep\u00fablica em S\u00e3o Paulo"},{"issue":"1","key":"10.1016\/j.bpc.2023.107041_bb0230","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0003-2697(02)00232-4","article-title":"Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-Asparaginase in human serum","volume":"309","author":"Lanvers","year":"2002","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.bpc.2023.107041_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-78549-y","article-title":"Implementation of the Asparaginase activity assessment technique for clinical use: experience of a Brazilian center","volume":"10","author":"Cecconello","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bpc.2023.107041_bb0240","article-title":"Amyloidogenicity of peptides targeting diabetes and obesity","author":"Lima","year":"2021","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bpc.2023.107041_bb0245","series-title":"Tailoring Structure \u2013 Function Properties of L -Asparaginase\u00a0: Engineering Resistance to Trypsin Cleavage","first-page":"337","volume":"343","author":"Kotzia","year":"2007"},{"issue":"7","key":"10.1016\/j.bpc.2023.107041_bb0250","first-page":"1964","article-title":"A dyad of lymphoblastic lysosomal cysteine proteases degrades the Antileukemic drug L-Asparaginase","volume":"119","author":"Patel","year":"2009","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.bpc.2023.107041_bb0255","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3109\/10428194.2014.1003056","article-title":"Asparaginase pharmacokinetics and implications of therapeutic drug monitoring","volume":"56","author":"Asselin","year":"2015","journal-title":"Leuk. Lymphoma"},{"issue":"3","key":"10.1016\/j.bpc.2023.107041_bb0260","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3324\/haematol.2015.137380","article-title":"Consensus expert recommendations for identification and Management of Asparaginase Hypersensitivity and Silent Inactivation","volume":"101","author":"van der Sluis","year":"2016","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.bpc.2023.107041_bb0265","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s004310050878","article-title":"Increased serum trypsin and Elastase-1 levels in patients undergoing L-Asparaginase therapy","volume":"157","author":"Shimizu","year":"1998","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bpc.2023.107041_bb0270","article-title":"L-Asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia","author":"Sahu","year":"2009","journal-title":"Pediatr. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bpc.2023.107041_bb0275","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0167-4838(89)90026-5","article-title":"On the role of histidine and tyrosine residues in E. Coli Asparaginase. Chemical modification and 1H-nuclear magnetic resonance studies","volume":"999","author":"Bagert","year":"1989","journal-title":"Biochim. Biophys. Acta Protein Struct. Mol. Enzymol."},{"issue":"2","key":"10.1016\/j.bpc.2023.107041_bb0280","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0167-4838(00)00179-5","article-title":"Dynamics of a Mobile loop at the active site of Escherichia Coli Asparaginase","volume":"1481","author":"Aung","year":"2000","journal-title":"Biochim. Biophys. Acta Protein Struct. Mol. Enzymol."},{"issue":"6","key":"10.1016\/j.bpc.2023.107041_bb0285","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1182\/blood.V99.6.1986","article-title":"A randomized comparison of NativeEscherichia Coli Asparaginase and polyethylene glycol conjugated Asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children\u2019s Cancer group study","volume":"99","author":"Avramis","year":"2002","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bpc.2023.107041_bb0290","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/s41587-022-01432-w","article-title":"Single-sequence protein structure prediction using a language model and deep learning","volume":"40","author":"Chowdhury","year":"2022","journal-title":"Nat. Biotechnol."}],"container-title":["Biophysical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462223000923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462223000923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:59:38Z","timestamp":1759564778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301462223000923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":58,"alternative-id":["S0301462223000923"],"URL":"https:\/\/doi.org\/10.1016\/j.bpc.2023.107041","relation":{},"ISSN":["0301-4622"],"issn-type":[{"value":"0301-4622","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutations in asparaginase II from E. coli and implications for inactivation and PEGylation","name":"articletitle","label":"Article Title"},{"value":"Biophysical Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpc.2023.107041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107041"}}